Elevated intrinsic G-CSF observed in severe congenital neutropenia also increases the risk for acute myeloid leukemia and myelodysplastic syndrome (MDS), in addition to the treatment with G-CSF (38). The gene discussed is CSF3; the disease is myelodysplastic syndrome.